{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:37:38Z","timestamp":1785148658840,"version":"3.55.0"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,25]]},"DOI":"10.18632\/oncotarget.15886","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T19:26:05Z","timestamp":1488655565000},"page":"28042-28051","source":"Crossref","is-referenced-by-count":29,"title":["miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Zhihong","family":"Zhuo","sequence":"first","affiliation":[{"name":"Ningbo No. 2 Hospital, 315010 Ningbo, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yu","sequence":"additional","affiliation":[{"name":"Ningbo No. 2 Hospital, 315010 Ningbo, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Vergote","year":"2005","journal-title":"Lancet"},{"key":"2","first-page":"10","article-title":"Cancer statistics","volume":"62","author":"Jemal","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"3","first-page":"72","article-title":"Endometrial carcinoma: pathology and genetics","volume":"39","author":"Catasus","year":"2007","journal-title":"Pathology"},{"key":"4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ygyno.2004.10.031","article-title":"Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of literature","volume":"97","author":"Woolas","year":"2005","journal-title":"Gynecol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in yonng women: central pathologic review and treatment outcome","volume":"167","author":"Nakano","year":"2001","journal-title":"Cancer Lett"},{"key":"6","doi-asserted-by":"crossref","first-page":"e13599","DOI":"10.1371\/journal.pone.0013599","article-title":"Expression of Versican 3\u2032-Untranslated Region Modulates Endogenous MicroRNA Functions","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS ONE"},{"key":"7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cell.2005.11.023","article-title":"Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3\u2032UTR evolution","volume":"123","author":"Cohen","year":"2005","journal-title":"Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"9","first-page":"1353","article-title":"Big roles of microRNAs in tumorigenesis and tumor development","volume":"26","author":"Fan","year":"2011","journal-title":"Histology & Histopathology"},{"key":"10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2010.09.022","article-title":"The expression of the miRNA-200 family in endometrial endometrioid carcinoma","volume":"120","author":"Kim","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1349-7006.2009.01385.x","article-title":"Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas","volume":"101","author":"Yaegashi","year":"2010","journal-title":"Cancer Science"},{"key":"12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0028-1096128","article-title":"MicroRNA Signature and Regulatory Functions in the Endometrium during","volume":"26","author":"Chegini","year":"2008","journal-title":"Normal and Disease States. Semin Reprod Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/0008-5472.CAN-09-1891","article-title":"Repression of FOXO1 expression by microRNAs in endometrial cancer","volume":"70","author":"Lam","year":"2010","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ijc.27840","article-title":"Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients","volume":"132","author":"Maciejewski","year":"2013","journal-title":"Int J Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ijc.24071","article-title":"Dysregulated micro RNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women","volume":"124","author":"Mok","year":"2009","journal-title":"Int J Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CEJ.0b013e328305a07a","article-title":"Expression profile of mammalian micro RNAs in endometrioid adenocarcinoma","volume":"18","author":"Liang","year":"2009","journal-title":"Eur J Cancer Prev"},{"key":"17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1349-7006.2009.01385.x","article-title":"Changes in micro RNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas","volume":"101","author":"Yaegashi","year":"2010","journal-title":"Cancer Sci"},{"key":"18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2010.05.010","article-title":"Micro RNA signatures differentiate uterine cancer tumor subtypes","volume":"118","author":"Weidhaas","year":"2010","journal-title":"Gynecol Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1242\/jcs.056812","article-title":"A putative role for micro RNA-205 in mammary epithelial cell progenitors","volume":"123","author":"Rosen","year":"2010","journal-title":"J Cell Sci"},{"key":"20","first-page":"e41532","article-title":"MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression","volume":"7","author":"Zhu","year":"2012","journal-title":"Plos One"},{"key":"21","first-page":"2864","article-title":"miR-200a\/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2009.25","article-title":"Aberrant servivin expression in endometrial hyperplasia: another of progestin resistance","volume":"22","author":"Zheng","year":"2009","journal-title":"Mod Pathol"},{"key":"23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1541-7786.MCR-15-0431","article-title":"Active FOXO1 is a Key Determinant of Isoform-Specific Progesterone Receptor 2Transactivation and Senescence Programming","volume":"14","author":"Lange","year":"2016","journal-title":"Mol Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/1471-2407-14-440","article-title":"MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer ishikawa cells","volume":"14","author":"Zhao","year":"2014","journal-title":"BMC Cancer"},{"issue":"411","key":"25","first-page":"355","article-title":"Oncogenic kinase signaling","volume":"2001","author":"Hunter","journal-title":"Nature"},{"key":"26","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1177\/1947601912445376","article-title":"Regulation of PI3K, PTEN, p53, and mTOR in malignant and benign tumors deficient in tuberin","volume":"2","author":"Valente","year":"2011","journal-title":"Genes Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0002-9440(10)64656-1","article-title":"Pten, a Proteant tumor suppressor","volume":"158","author":"Mutter","journal-title":"Am J Pathol"},{"key":"28","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","article-title":"PTEN signaling pathways in melanoma","volume":"22","author":"Haluska","year":"2003","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Eng","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S","article-title":"PTEN methy1ation is associated with advanced stage and microsatellite in stability in endometrial careinoma","volume":"91","author":"Das","year":"2001","journal-title":"Int J Cancer"},{"key":"31","first-page":"3005","article-title":"PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin Caneer Res"},{"key":"32","first-page":"272","article-title":"Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma","volume":"132","author":"Huimin","year":"2016","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"33","first-page":"24","article-title":"Multiple Functions in Human Malignant Tumors","volume":"5","author":"Ciuffreda","year":"2015","journal-title":"Front Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.27.061406.093749","article-title":"Protein turnover via autophagy: implications for metabolism","volume":"27","author":"Klionsky","year":"2007","journal-title":"Ann Nutrition"},{"key":"35","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1101\/gad.17558811","article-title":"The dynamic nature of autophagy in cancer","volume":"25","author":"Kimmelman","year":"2011","journal-title":"Genes Dev"},{"key":"36","first-page":"139","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Guan","year":"2011","journal-title":"Nature cell biology"},{"key":"37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceb.2009.11.014","article-title":"Mammalian autophagy: core molecular machinery and signaling regulation","volume":"22","author":"Klionsky","year":"2010","journal-title":"Curr Opin Cell Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:44:32Z","timestamp":1589136272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":37,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,25]]}},"alternative-id":["15886","28427207"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15886","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]}}}